newsfilter
← Latest News
Business Wire·

Frequency Therapeutics Provides Statement of Support for the Hearing Loss Association of America's Externally-Led Patient-Focused Drug Development Meeting to Address Sensorineural Hearing Loss

Frequency Therapeutics, Inc., (NASDAQ:FREQ) today shared a statement from David L. Lucchino, Frequency's Chief Executive Officer, in support of the Hearing Loss Association of America (HLAA) and its efforts to advance the voice of the patient in leading